Cargando…

ESMO and WHO: 14 years of working in partnership on cancer control

Detalles Bibliográficos
Autores principales:	Ullrich, Andreas, Ciardiello, Fortunato, Bricalli, Gracemarie, Cherny, Nathan I, Eniu, Alexandru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2016
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070389/ https://www.ncbi.nlm.nih.gov/pubmed/27843600 http://dx.doi.org/10.1136/esmoopen-2015-000012

Ejemplares similares

Back to the ‘essence’ of medical treatment in oncology: the 2015 WHO Model List of Essential Medicines
por: Eniu, Alexandru, et al.
Publicado: (2016)

Cancer medicines in Asia and Asia-Pacific: What is available, and is it effective enough?
por: Eniu, Alexandru, et al.
Publicado: (2019)

Applying the ESMO-Magnitude of Clinical Benefit Scale in real life
por: Ciardiello, Fortunato, et al.
Publicado: (2016)

ESMO gave me a chance to help make a difference: a personal reflection on the occasion of receiving the 2015 ESMO Award
por: Cherny, Nathan I
Publicado: (2016)

ESMO International Consortium Study on the availability, out-of-pocket costs and accessibility of antineoplastic medicines in countries outside of Europe
por: Cherny, N I, et al.
Publicado: (2017)

WHO-ESMO collaboration in cancer control: policies into action to save lives
por: Mikkelsen, B., et al.
Publicado: (2022)

“The first ones now, will later be last”: understanding the importance of historical context when reading ESMO-MCBS scores
por: Cherny, N.I., et al.
Publicado: (2022)

Detailed statistical assessment of the characteristics of the ESMO Magnitude of Clinical Benefit Scale (ESMO-MCBS) threshold rules
por: Dafni, Urania, et al.
Publicado: (2017)

Implementation of the ESMO-Magnitude of Clinical Benefit Scale: real world example from the 2022 Israeli National Reimbursement Process
por: Wolf, I., et al.
Publicado: (2022)

Indicators of integration at ESMO Designated Centres of Integrated Oncology and Palliative Care
por: Hui, David, et al.
Publicado: (2018)

AIOM chooses ESMO Open—Cancer Horizons as its official journal: a warm welcome from ESMO Open
por: Zielinski, Christoph C, et al.
Publicado: (2016)

Evaluation of the ESMO-Magnitude of Clinical Benefit Scale version 1.1 (ESMO-MCBS v1.1) for adjuvant radiotherapy in breast cancer
por: Sapir, E., et al.
Publicado: (2023)

CSCO joins ESMO Open—Cancer Horizons
por: Zielinski, Christoph C, et al.
Publicado: (2016)

ESMO Open—Cancer Horizons and the future of oncology
por: Zielinski, Christoph C
Publicado: (2016)

ESMO pays tribute to Professor José Baselga
por: Peters, S., et al.
Publicado: (2021)

One year of ESMO Open: Cancer Horizons—where are we going from here?
por: Zielinski, Christoph
Publicado: (2017)

PB2707: ESMO-MAGNITUDE OF CLINICAL BENEFIT SCALE FOR HAEMATOLOGICAL MALIGNANCIES (ESMO-MCBS:H) VERSION 1.0
por: Kiesewetter, Barbara, et al.
Publicado: (2023)

Educational needs in gastrointestinal cancer: a consensus position paper from the ESMO Gastrointestinal Cancer Faculty
por: Lordick, Florian, et al.
Publicado: (2019)

Career opportunities and benefits for young oncologists in the European Society for Medical Oncology (ESMO)
por: Morgan, Gilberto, et al.
Publicado: (2016)

Tobacco cessation and the role of ESMO and medical oncologists: addressing the specific needs of cancer patients in times of the COVID-19 pandemic
por: Krech, R., et al.
Publicado: (2023)

Challenge of implementing clinical practice guidelines. Getting ESMO’s guidelines even closer to the bedside: introducing the ESMO Practising Oncologists’ checklists and knowledge and practice questions
por: Rauh, Stefan, et al.
Publicado: (2018)

EHA evaluation of the ESMO—Magnitude of Clinical Benefit Scale version 1.1 (ESMO-MCBS v1.1) for haematological malignancies
por: Kiesewetter, Barbara, et al.
Publicado: (2020)

ESMO Copenhagen 2016: a lung cancer ‘grand cru’
por: Douillard, Jean-Yves
Publicado: (2017)

Introducing pro and con discussions in ESMO Open—Cancer Horizons
por: Zielinski, C., et al.
Publicado: (2022)

Global cancer control: responding to the growing burden, rising costs and inequalities in access
por: Prager, Gerald W, et al.
Publicado: (2018)

Application of the ESMO-Magnitude of Clinical Benefit Scale (V.1.1) to the field of early breast cancer therapies
por: Paluch-Shimon, Shani, et al.
Publicado: (2020)

The ESMO/ASCO Global Curriculum and the evolution of medical oncology training in Europe
por: Pavlidis, Nicholas, et al.
Publicado: (2016)

ESMO Open welcomes the association with the Japanese Society of Medical Oncology (JSMO)
por: Ohe, Yuichiro, et al.
Publicado: (2017)

EHA Endorsement of ESMO Clinical Practice Guidelines for Marginal Zone Lymphomas
por: Ladetto, Marco, et al.
Publicado: (2020)

40 Years of the APOC Partnership
por: Roungou, Jean-Baptist, et al.
Publicado: (2015)

Biases in study design, implementation, and data analysis that distort the appraisal of clinical benefit and ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) scoring
por: Gyawali, B., et al.
Publicado: (2021)

The ESMO position paper on biosimilars in oncology: enhancing the provision of accurate education and information
por: Schiestl, Martin, et al.
Publicado: (2017)

Announcing the ESMO Open special issue on upcoming molecular targets for cancer treatment
por: Morgan, Gilberto, et al.
Publicado: (2020)

50 Years of Children’s HeartLink and the Partnerships in Brazil
por: Croti, Ulisses, et al.
Publicado: (2020)

ESMO - Magnitude of Clinical Benefit Scale V.1.0 questions and answers
por: Cherny, N I, et al.
Publicado: (2016)

From ESMO 2022
por: Romero, Diana
Publicado: (2022)

ESMO/ASCO recommendations for a Global Curriculum (GC) in medical oncology—edition 2016
por: Dittrich, C., et al.
Publicado: (2016)

The hard road to ranking the clinical benefit of antineoplastic agents: ESMO Award 2016 presentation
por: Sobrero, Alberto
Publicado: (2017)

EHA Endorsement of ESMO Clinical Practice Guidelines for Newly Diagnosed and Relapsed Follicular Lymphoma
por: Ladetto, Marco, et al.
Publicado: (2021)

ESMO Clinical Practice Guidelines: adapting and adopting new approaches for development, implementation and audit
por: Pentheroudakis, G., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ceqma5451cllmbfvdlkuhpprt7